| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0.004 | 0.949 | Antiinflammatory | 0.668 0.037 DBMET03211 0.946 0.005 DBMET03212 | ||
| 0.946 | 0.002 | 0.946 | Androgen antagonist | 0.41 0.005 DBMET03211 0.683 0.003 DBMET03212 | ||
| 0.854 | 0.01 | 0.866 | Transcription factor NF kappa B inhibitor | 0.664 0.025 DBMET03211 0.866 0.009 DBMET03212 | DBMET03212 | |
| 0.845 | 0.001 | 0.845 | Androgen agonist | 0.501 0.002 DBMET03211 0.398 0.002 DBMET03212 | ||
| 0.845 | 0.003 | 0.845 | Hypoxia-inducible factor 1 alpha inhibitor | 0.634 0.006 DBMET03211 0.772 0.003 DBMET03212 | ||
| 0.837 | 0.002 | 0.837 | Antipruritic | 0.377 0.008 DBMET03211 0.545 0.004 DBMET03212 | ||
| 0.762 | 0.003 | 0.762 | Anesthetic general | 0.675 0.004 DBMET03211 0.694 0.003 DBMET03212 | ||
| 0.762 | 0.005 | 0.801 | Cholesterol antagonist | 0.801 0.004 DBMET03211 0.641 0.014 DBMET03212 | DBMET03211 | |
| 0.756 | 0.001 | 0.756 | Progesterone antagonist | 0.288 0.004 DBMET03211 0.565 0.002 DBMET03212 | ||
| 0.746 | 0.024 | 0.749 | Apoptosis agonist | 0.637 0.042 DBMET03211 0.749 0.023 DBMET03212 | DBMET03212 | |
| 0.706 | 0.002 | 0.706 | Aromatase inhibitor | 0.539 0.003 DBMET03211 0.488 0.003 DBMET03212 | ||
| 0.703 | 0.001 | 0.703 | Lipocortins synthesis antagonist | 0.538 0.003 DBMET03211 0.668 0.001 DBMET03212 | ||
| 0.701 | 0.005 | 0.701 | Immunosuppressant | 0.576 0.016 DBMET03211 0.666 0.006 DBMET03212 | ||
| 0.687 | 0.025 | 0.764 | Caspase 9 stimulant | 0.764 0.016 DBMET03211 0.337 0.156 DBMET03212 | DBMET03211 | |
| 0.657 | 0.012 | 0.657 | Aldehyde oxidase inhibitor | 0.555 0.025 DBMET03211 0.342 0.057 DBMET03212 | ||
| 0.639 | 0.004 | 0.65 | Diuretic | 0.5 0.008 DBMET03211 0.65 0.004 DBMET03212 | DBMET03212 | |
| 0.59 | 0.018 | 0.59 | Toll-Like receptor agonist | 0.484 0.035 DBMET03212 | ||
| 0.569 | 0.003 | 0.569 | Interferon gamma antagonist | 0.504 0.006 DBMET03211 0.449 0.008 DBMET03212 | ||
| 0.582 | 0.019 | 0.582 | Toll-Like receptor 7 agonist | 0.489 0.034 DBMET03212 | ||
| 0.528 | 0.001 | 0.528 | Glucocorticoid agonist | 0.084 0.003 DBMET03211 0.416 0.001 DBMET03212 | ||
| 0.52 | 0.002 | 0.52 | Glucocorticoid antagonist | 0.2 0.003 DBMET03211 0.424 0.002 DBMET03212 | ||
| 0.512 | 0.008 | 0.513 | P-glycoprotein inhibitor | 0.246 0.042 DBMET03211 0.513 0.008 DBMET03212 | DBMET03212 | |
| 0.484 | 0.002 | 0.484 | Aldosterone antagonist | 0.279 0.003 DBMET03211 0.34 0.003 DBMET03212 | ||
| 0.484 | 0.005 | 0.484 | NOS3 expression enhancer | 0.394 0.008 DBMET03211 0.376 0.009 DBMET03212 | ||
| 0.477 | 0 | 0.477 | Arachidonic acid antagonist | 0.344 0.001 DBMET03211 0.374 0.001 DBMET03212 | ||
| 0.466 | 0.006 | 0.466 | Sodium/bile acid cotransporter inhibitor | 0.455 0.007 DBMET03211 0.44 0.009 DBMET03212 | ||
| 0.436 | 0.002 | 0.436 | 5-Alpha-reductase inhibitor | 0.34 0.003 DBMET03211 0.349 0.002 DBMET03212 | ||
| 0.451 | 0.019 | 0.451 | DNA damaging | 0.335 0.045 DBMET03211 0.397 0.029 DBMET03212 | ||
| 0.427 | 0.001 | 0.427 | 5-Alpha-reductase 1 inhibitor | 0.311 0.002 DBMET03211 0.168 0.003 DBMET03212 | ||
| 0.412 | 0.001 | 0.412 | Progesterone agonist | 0.154 0.003 DBMET03211 0.336 0.001 DBMET03212 | ||
| 0.41 | 0.004 | 0.41 | Estrogen agonist | 0.348 0.005 DBMET03211 0.264 0.006 DBMET03212 | ||
| 0.4 | 0.001 | 0.4 | 5-Alpha-reductase 2 inhibitor | 0.306 0.002 DBMET03211 0.18 0.003 DBMET03212 | ||
| 0.393 | 0.003 | 0.393 | Mineralocorticoid receptor antagonist | 0.213 0.004 DBMET03211 0.287 0.004 DBMET03212 | ||
| 0.396 | 0.008 | 0.396 | Interleukin 6 antagonist | 0.233 0.027 DBMET03211 0.33 0.011 DBMET03212 | ||
| 0.412 | 0.024 | 0.463 | Interleukin 2 agonist | 0.463 0.013 DBMET03211 0.357 0.042 DBMET03212 | DBMET03211 | |
| 0.416 | 0.034 | 0.416 | Apoptosis antagonist | 0.406 0.037 DBMET03211 0.412 0.035 DBMET03212 | ||
| 0.373 | 0.005 | 0.373 | Cholesterol synthesis inhibitor | 0.362 0.006 DBMET03211 0.204 0.026 DBMET03212 | ||
| 0.366 | 0.001 | 0.425 | Anabolic | 0.425 0.001 DBMET03211 0.214 0.003 DBMET03212 | DBMET03211 | |
| 0.356 | 0.005 | 0.356 | Estrogen antagonist | 0.3 0.006 DBMET03211 0.247 0.009 DBMET03212 | ||
| 0.348 | 0.004 | 0.348 | Estrogen receptor alpha antagonist | 0.188 0.009 DBMET03211 0.124 0.017 DBMET03212 | ||
| 0.342 | 0.003 | 0.425 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.425 0.003 DBMET03211 0.021 0.013 DBMET03212 | DBMET03211 | |
| 0.357 | 0.031 | 0.357 | Nitric oxide antagonist | 0.347 0.032 DBMET03211 0.333 0.034 DBMET03212 | ||
| 0.375 | 0.057 | 0.377 | Immunostimulant | 0.377 0.056 DBMET03211 0.332 0.07 DBMET03212 | DBMET03211 | |
| 0.325 | 0.015 | 0.325 | Topoisomerase II inhibitor | 0.312 0.016 DBMET03212 | ||
| 0.315 | 0.006 | 0.315 | Topoisomerase II alpha inhibitor | 0.221 0.012 DBMET03212 | ||
| 0.324 | 0.019 | 0.371 | Melanin inhibitor | 0.371 0.014 DBMET03211 0.184 0.049 DBMET03212 | DBMET03211 | |
| 0.294 | 0.002 | 0.497 | RNA-directed RNA polymerase stimulant | 0.497 0.001 DBMET03211 0.248 0.002 DBMET03212 | DBMET03211 | |
| 0.289 | 0.012 | 0.289 | DNA intercalator | 0.285 0.013 DBMET03212 | ||
| 0.325 | 0.053 | 0.358 | Antioxidant | 0.358 0.044 DBMET03211 0.321 0.055 DBMET03212 | DBMET03211 | |
| 0.279 | 0.014 | 0.279 | Alkylator | 0.173 0.036 DBMET03211 0.202 0.026 DBMET03212 | ||
| 0.264 | 0.001 | 0.264 | Corticosteroid-like | 0.094 0.002 DBMET03211 0.176 0.001 DBMET03212 | ||
| 0.294 | 0.031 | 0.294 | Hepatoprotectant | 0.285 0.034 DBMET03211 0.257 0.041 DBMET03212 | ||
| 0.25 | 0.001 | 0.25 | Lipocortins synthesis agonist | 0.144 0.002 DBMET03211 0.202 0.001 DBMET03212 | ||
| 0.316 | 0.071 | 0.316 | Caspase 3 stimulant | 0.221 0.142 DBMET03211 0.293 0.082 DBMET03212 | ||
| 0.275 | 0.032 | 0.275 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.231 0.052 DBMET03211 0.222 0.057 DBMET03212 | ||
| 0.268 | 0.029 | 0.291 | Neurotrophic factor enhancer | 0.291 0.02 DBMET03211 0.186 0.091 DBMET03212 | DBMET03211 | |
| 0.289 | 0.054 | 0.404 | Interleukin agonist | 0.404 0.018 DBMET03211 | DBMET03211 | |
| 0.288 | 0.054 | 0.324 | Angiogenesis stimulant | 0.324 0.041 DBMET03211 0.192 0.099 DBMET03212 | DBMET03211 | |
| 0.255 | 0.026 | 0.259 | Lipid peroxidase inhibitor | 0.214 0.036 DBMET03211 0.259 0.025 DBMET03212 | DBMET03212 | |
| 0.242 | 0.014 | 0.242 | Interleukin 4 antagonist | 0.131 0.07 DBMET03211 0.15 0.049 DBMET03212 | ||
| 0.278 | 0.052 | 0.294 | DNA synthesis inhibitor | 0.214 0.102 DBMET03211 0.294 0.046 DBMET03212 | DBMET03212 | |
| 0.233 | 0.014 | 0.258 | Farnesoid X receptor antagonist | 0.258 0.01 DBMET03211 0.181 0.029 DBMET03212 | DBMET03211 | |
| 0.241 | 0.029 | 0.248 | Protein kinase stimulant | 0.211 0.038 DBMET03211 0.248 0.027 DBMET03212 | DBMET03212 | |
| 0.231 | 0.02 | 0.242 | Topoisomerase I inhibitor | 0.242 0.018 DBMET03212 | DBMET03212 | |
| 0.233 | 0.026 | 0.235 | Monophenol monooxygenase inhibitor | 0.217 0.029 DBMET03211 0.235 0.026 DBMET03212 | DBMET03212 | |
| 0.293 | 0.086 | 0.293 | Immunomodulator | 0.247 0.117 DBMET03211 0.254 0.112 DBMET03212 | ||
| 0.212 | 0.009 | 0.212 | Estrogen receptor beta antagonist | 0.17 0.012 DBMET03211 0.148 0.016 DBMET03212 | ||
| 0.332 | 0.137 | 0.345 | Cyclophilin D inhibitor | 0.345 0.126 DBMET03212 | DBMET03212 | |
| 0.216 | 0.024 | 0.217 | DNA polymerase I inhibitor | 0.217 0.023 DBMET03211 0.162 0.043 DBMET03212 | DBMET03211 | |
| 0.215 | 0.024 | 0.215 | Aldehyde dehydrogenase inhibitor | 0.203 0.027 DBMET03211 0.111 0.081 DBMET03212 | ||
| 0.191 | 0.005 | 0.191 | Estrogen receptor beta agonist | 0.166 0.006 DBMET03211 0.142 0.008 DBMET03212 | ||
| 0.233 | 0.05 | 0.233 | Non-steroidal antiinflammatory agent | 0.147 0.118 DBMET03211 0.144 0.123 DBMET03212 | ||
| 0.201 | 0.021 | 0.201 | Antineoplastic antibiotic | 0.109 0.042 DBMET03211 0.161 0.029 DBMET03212 | ||
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 DBMET03211 0.143 0.064 DBMET03212 | ||
| 0.169 | 0.005 | 0.169 | Estrogen receptor alpha agonist | 0.15 0.005 DBMET03211 0.112 0.007 DBMET03212 | ||
| 0.175 | 0.014 | 0.175 | Prolactin inhibitor | 0.155 0.02 DBMET03211 | ||
| 0.166 | 0.008 | 0.166 | Interleukin 5 antagonist | 0.087 0.059 DBMET03211 0.12 0.023 DBMET03212 | ||
| 0.166 | 0.008 | 0.247 | Ornithine decarboxylase inhibitor | 0.123 0.023 DBMET03211 0.247 0.004 DBMET03212 | DBMET03212 | |
| 0.219 | 0.07 | 0.369 | Psychostimulant | 0.369 0.028 DBMET03211 | DBMET03211 | |
| 0.15 | 0.007 | 0.201 | Glycine receptor agonist | 0.201 0.004 DBMET03211 0.074 0.047 DBMET03212 | DBMET03211 | |
| 0.214 | 0.077 | 0.214 | Interleukin antagonist | |||
| 0.284 | 0.148 | 0.321 | Antibacterial | 0.245 0.181 DBMET03211 0.321 0.12 DBMET03212 | DBMET03212 | |
| 0.137 | 0.004 | 0.137 | Estrone sulfatase inhibitor | 0.096 0.005 DBMET03211 0.118 0.004 DBMET03212 | ||
| 0.194 | 0.061 | 0.23 | Growth hormone agonist | 0.23 0.049 DBMET03211 | DBMET03211 | |
| 0.148 | 0.016 | 0.148 | Inducible nitric-oxide synthase inhibitor | |||
| 0.14 | 0.01 | 0.22 | Glycine receptor antagonist | 0.22 0.003 DBMET03211 | DBMET03211 | |
| 0.139 | 0.008 | 0.144 | Na+ K+ transporting ATPase inhibitor | 0.144 0.007 DBMET03211 0.128 0.012 DBMET03212 | DBMET03211 | |
| 0.151 | 0.021 | 0.158 | Toll-Like receptor 4 antagonist | 0.158 0.017 DBMET03211 0.109 0.057 DBMET03212 | DBMET03211 | |
| 0.158 | 0.029 | 0.158 | Interleukin 8 antagonist | 0.137 0.043 DBMET03211 0.155 0.031 DBMET03212 | ||
| 0.183 | 0.058 | 0.205 | Phospholipase C inhibitor | 0.205 0.041 DBMET03211 | DBMET03211 | |
| 0.165 | 0.041 | 0.192 | Adenylate cyclase stimulant | 0.192 0.018 DBMET03211 | DBMET03211 | |
| 0.124 | 0.002 | 0.124 | Glucose-6-phosphate dehydrogenase inhibitor | 0.078 0.004 DBMET03211 0.105 0.003 DBMET03212 | ||
| 0.155 | 0.035 | 0.226 | Microtubule formation inhibitor | 0.226 0.014 DBMET03211 0.213 0.017 DBMET03212 | DBMET03211 | |
| 0.157 | 0.041 | 0.22 | Pregnane X receptor agonist | 0.22 0.007 DBMET03211 | DBMET03211 | |
| 0.155 | 0.047 | 0.248 | Anesthetic local | 0.188 0.036 DBMET03211 0.248 0.02 DBMET03212 | DBMET03212 | |
| 0.112 | 0.008 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.151 0.005 DBMET03211 0.072 0.02 DBMET03212 | DBMET03211 | |
| 0.149 | 0.046 | 0.221 | Adenylate cyclase inhibitor | 0.221 0.022 DBMET03211 | DBMET03211 | |
| 0.112 | 0.009 | 0.154 | Estradiol 17 beta-dehydrogenase inhibitor | 0.154 0.006 DBMET03211 0.041 0.03 DBMET03212 | DBMET03211 | |
| 0.206 | 0.104 | 0.206 | Tumour necrosis factor alpha release inhibitor | |||
| 0.107 | 0.006 | 0.119 | Nitric oxide donor | 0.074 0.029 DBMET03211 0.119 0.004 DBMET03212 | DBMET03212 | |
| 0.138 | 0.04 | 0.205 | Expectorant | 0.205 0.019 DBMET03212 | DBMET03212 | |
| 0.1 | 0.004 | 0.148 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.148 0.003 DBMET03211 0.04 0.016 DBMET03212 | DBMET03211 | |
| 0.099 | 0.004 | 0.136 | Pregnane X receptor antagonist | 0.136 0.002 DBMET03211 0.065 0.022 DBMET03212 | DBMET03211 | |
| 0.115 | 0.025 | 0.145 | Bile acid receptor antagonist | 0.145 0.008 DBMET03211 | DBMET03211 | |
| 0.215 | 0.127 | 0.239 | Gastrin inhibitor | 0.239 0.093 DBMET03211 | DBMET03211 | |
| 0.127 | 0.043 | 0.143 | AMP-activated protein kinase stimulant | 0.143 0.033 DBMET03211 | DBMET03211 | |
| 0.144 | 0.064 | 0.144 | Bone formation stimulant | 0.118 0.088 DBMET03211 | ||
| 0.127 | 0.048 | 0.129 | Mucolytic | 0.129 0.047 DBMET03212 | DBMET03212 | |
| 0.068 | 0.001 | 0.068 | Transcortin receptor antagonist | 0.016 0.002 DBMET03211 0.032 0.001 DBMET03212 | ||
| 0.071 | 0.006 | 0.087 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.087 0.005 DBMET03211 0.049 0.008 DBMET03212 | DBMET03211 | |
| 0.096 | 0.033 | 0.146 | Keratolytic | 0.123 0.02 DBMET03211 0.146 0.015 DBMET03212 | DBMET03212 | |
| 0.105 | 0.044 | 0.129 | ABCA1 expression enhancer | 0.129 0.025 DBMET03211 0.085 0.076 DBMET03212 | DBMET03211 | |
| 0.078 | 0.016 | 0.091 | Heme oxygenase stimulant | 0.091 0.01 DBMET03211 0.072 0.023 DBMET03212 | DBMET03211 | |
| 0.094 | 0.033 | 0.112 | Estrogen-related receptor beta agonist | 0.112 0.014 DBMET03211 | DBMET03211 | |
| 0.172 | 0.116 | 0.239 | Hypolipemic | 0.239 0.072 DBMET03211 0.236 0.074 DBMET03212 | DBMET03211 | |
| 0.14 | 0.085 | 0.14 | Acetylcholine M1 receptor antagonist | |||
| 0.154 | 0.101 | 0.217 | Platelet adhesion inhibitor | 0.217 0.062 DBMET03211 0.134 0.126 DBMET03212 | DBMET03211 | |
| 0.124 | 0.074 | 0.124 | Cyclooxygenase 3 inhibitor | 0.118 0.08 DBMET03211 0.123 0.074 DBMET03212 | ||
| 0.125 | 0.078 | 0.136 | Amylase inhibitor | 0.136 0.072 DBMET03211 | DBMET03211 | |
| 0.18 | 0.136 | 0.18 | Spasmolytic | |||
| 0.084 | 0.052 | 0.084 | T cell inhibitor | |||
| 0.054 | 0.026 | 0.054 | Adenosine deaminase inhibitor | |||
| 0.052 | 0.026 | 0.057 | Microtubule stabilization | 0.054 0.022 DBMET03211 0.057 0.019 DBMET03212 | DBMET03212 | |
| 0.145 | 0.122 | 0.149 | Succinate dehydrogenase inhibitor | 0.149 0.114 DBMET03211 | DBMET03211 | |
| 0.024 | 0.003 | 0.024 | Progesterone receptor A antagonist | 0.011 0.005 DBMET03211 0.01 0.006 DBMET03212 | ||
| 0.042 | 0.023 | 0.042 | GABA uptake inhibitor | |||
| 0.03 | 0.013 | 0.04 | Hedgehog signaling activator | 0.04 0.005 DBMET03211 | DBMET03211 | |
| 0.081 | 0.064 | 0.081 | Antineoplastic alkaloid | 0.078 0.068 DBMET03211 | ||
| 0.019 | 0.003 | 0.022 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.022 0.003 DBMET03211 0.017 0.004 DBMET03212 | DBMET03211 | |
| 0.023 | 0.008 | 0.023 | Progesterone receptor B antagonist | 0.02 0.013 DBMET03212 | ||
| 0.02 | 0.007 | 0.02 | Vitamin D receptor agonist | 0.017 0.01 DBMET03211 | ||
| 0.049 | 0.041 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 DBMET03211 0.062 0.029 DBMET03212 | DBMET03212 | |
| 0.068 | 0.06 | 0.08 | CDC25A inhibitor | 0.08 0.043 DBMET03211 | DBMET03211 | |
| 0.021 | 0.017 | 0.022 | Vitamin D receptor antagonist | 0.022 0.014 DBMET03211 | DBMET03211 | |
| 0.016 | 0.015 | 0.022 | Telomerase stimulant | 0.022 0.006 DBMET03211 | DBMET03211 | |
| 0.069 | 0.07 | 0.096 | Acetylcholine nicotinic antagonist | 0.096 0.042 DBMET03211 | DBMET03211 | |
| 0.038 | 0.04 | 0.046 | Liver X receptor agonist | 0.046 0.027 DBMET03211 | DBMET03211 | |
| 0.035 | 0.038 | 0.061 | Liver X receptor alpha agonist | 0.061 0.012 DBMET03211 | DBMET03211 | |
| 0.186 | 0.193 | 0.216 | Vasodilator, peripheral | 0.216 0.158 DBMET03211 | DBMET03211 | |
| 0.046 | 0.055 | 0.056 | HIV-1 integrase (Strand Transfer) inhibitor | 0.056 0.045 DBMET03211 | DBMET03211 | |
| 0.028 | 0.039 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.028 DBMET03211 | DBMET03211 | |
| 0.012 | 0.026 | 0.014 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.014 0.013 DBMET03211 | DBMET03211 | |
| 0.147 | 0.162 | 0.194 | Vasodilator | 0.185 0.118 DBMET03211 0.194 0.11 DBMET03212 | DBMET03212 | |
| 0.04 | 0.058 | 0.06 | Beta tubulin antagonist | 0.06 0.04 DBMET03211 0.05 0.047 DBMET03212 | DBMET03211 | |
| 0.14 | 0.159 | 0.263 | Free radical scavenger | 0.263 0.063 DBMET03211 | DBMET03211 | |
| 0.104 | 0.128 | 0.128 | Neurotrophic factor | 0.119 0.096 DBMET03211 0.128 0.084 DBMET03212 | DBMET03212 | |
| 0.043 | 0.081 | 0.053 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.049 DBMET03211 | DBMET03211 | |
| 0.01 | 0.048 | 0.041 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.041 0.008 DBMET03211 | DBMET03211 | |
| 0.136 | 0.175 | 0.183 | Growth factor agonist | 0.183 0.082 DBMET03211 | DBMET03211 | |
| 0.019 | 0.061 | 0.031 | Liver X receptor beta agonist | 0.031 0.026 DBMET03211 | DBMET03211 | |
| 0.072 | 0.116 | 0.092 | Protein-tyrosine phosphatase 1B inhibitor | 0.092 0.086 DBMET03211 | DBMET03211 | |
| 0.018 | 0.071 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET03211 | DBMET03211 | |
| 0.013 | 0.079 | 0.025 | Retinoic acid gamma receptor agonist | 0.025 0.01 DBMET03212 | DBMET03212 | |
| 0.137 | 0.205 | 0.169 | Hypoglycemic | 0.169 0.15 DBMET03211 | DBMET03211 | |
| 0.078 | 0.148 | 0.114 | Photosensitizer | 0.114 0.064 DBMET03211 | DBMET03211 | |
| 0.011 | 0.096 | 0.024 | Retinoic acid receptor agonist | 0.024 0.015 DBMET03212 | DBMET03212 | |
| 0.071 | 0.158 | 0.101 | Hedgehog signaling inhibitor | 0.101 0.063 DBMET03211 | DBMET03211 | |
| 0.01 | 0.102 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.012 DBMET03212 | DBMET03212 | |
| 0.005 | 0.115 | 0.016 | Prostacyclin agonist | 0.016 0.011 DBMET03212 | DBMET03212 | |
| 0.156 | 0.27 | 0.218 | 5 Hydroxytryptamine uptake stimulant | 0.218 0.121 DBMET03211 | DBMET03211 | |
| 0.143 | 0.262 | 0.195 | Antithrombotic | 0.195 0.184 DBMET03211 | DBMET03211 | |
| 0.077 | 0.21 | 0.121 | Phospholipase A2 inhibitor | 0.121 0.116 DBMET03212 | DBMET03212 | |
| 0.113 | 0.313 | 0.189 | RNA-directed DNA polymerase inhibitor | 0.189 0.117 DBMET03211 | DBMET03211 | |
| 0.05 | 0.253 | 0.095 | Vanilloid agonist | 0.095 0.04 DBMET03212 | DBMET03212 | |
| 0.096 | 0.342 | 0.184 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 DBMET03211 | DBMET03211 | |
| 0.017 | 0.734 | 0.277 | Nav1.4 sodium channel blocker | 0.277 0.004 DBMET03211 | DBMET03211 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |